Fasinumab

• CAT Number: I043195
• CAS Number: 1190239-42-9
• Purity: ≥95%

Fasinumab (Anti-Human NGF) is a human IgG4 monoclonal antibody to nerve growth factor (NGF). Fasinumab can be used in acute sciatica and knee osteoarthritis (OA) studies[1].

Reference

[1]. Paul J Tiseo, et al. Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study. J Pain Res. 2014 Aug 22;7:523-30.
 [Content Brief]